Last update 08 May 2025

Interferon gamma(Novartis Pharma AG)

Overview

Basic Info

Drug Type
Interferons
Synonyms-
Target
IFNLR1
Action
agonists
Mechanism
IFNLR1 agonists(interferon lambda receptor 1 agonists)
Therapeutic Areas
Neoplasms
Active Indication-
Inactive Indication
Neoplasms
Originator Organization
Novartis Pharma AG
Active Organization-
Inactive Organization
Novartis Pharma AG
License Organization-
Drug Highest PhasePendingPhase 1
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Related

1
Clinical Trials associated with Interferon gamma(Novartis Pharma AG)
ISRCTN10449048
/ RecruitingPhase 2IIT
Can interferon gamma prevent infection in critically ill patients at highest risk? A phase II randomised controlled trial - INFINIT (INterFeron to reduce INfection in InTensive care units)
100 Clinical Results associated with Interferon gamma(Novartis Pharma AG)
Login to view more data
100 Translational Medicine associated with Interferon gamma(Novartis Pharma AG)
Login to view more data
100 Patents (Medical) associated with Interferon gamma(Novartis Pharma AG)
Login to view more data
100 Deals associated with Interferon gamma(Novartis Pharma AG)
Login to view more data

External Link

KEGGWikiATCDrug Bank
-Interferon gamma(Novartis Pharma AG)--

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
NeoplasmsPhase 1-
Novartis Pharma AG
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free